|
| | Publication Year | Title | Author(s) |
| 1 | 10-Nov-2014 | Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database. | Shi, Qian; de Gramont, Aimery; Grothey, Axel; Zalcberg, John; Chibaudel, Benoist; Schmoll, Hans-Joachim; Seymour, Matthew T; Adams, Richard A; Saltz, Leonard; Goldberg, Richard M; Punt, Cornelis J A; Douillard, Jean-Yves; Hoff, Paulo M; Hecht, Joel Randolph; Hurwitz, Herbert; Díaz-Rubio, Eduardo; Porschen, Rainer; Tebbutt, Niall C ; Fuchs, Charles; Souglakos, John; Falcone, Alfredo; Tournigand, Christophe; Kabbinavar, Fairooz F; Heinemann, Volker; Van Cutsem, Eric; Bokemeyer, Carsten; Buyse, Marc; Sargent, Daniel J |
| 2 | 29-Jul-2014 | The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials. | Segelov, E; Chan, David L; Shapiro, J; Price, Timothy J; Karapetis, C S; Tebbutt, Niall C ; Pavlakis, N |
| 3 | 12-Dec-2013 | Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. | Jonker, D J; Karapetis, C S; Harbison, C; O'Callaghan, Christopher J ; Tu, D; Simes, R J; Malone, D P; Langer, C; Tebbutt, Niall C ; Price, Timothy J; Shapiro, J; Siu, L L; Wong, R P W; Bjarnason, G; Moore, M J; Zalcberg, John R; Khambata-Ford, S |
| 4 | 3-Dec-2013 | Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. | Greenhalf, William; Ghaneh, Paula; Neoptolemos, John P; Palmer, Daniel H; Cox, Trevor F; Lamb, Richard F; Garner, Elizabeth; Campbell, Fiona; Mackey, John R; Costello, Eithne; Moore, Malcolm J; Valle, Juan W; McDonald, Alexander C; Carter, Ross; Tebbutt, Niall C ; Goldstein, David B; Shannon, Jennifer; Dervenis, Christos; Glimelius, Bengt; Deakin, Mark; Charnley, Richard M; Lacaine, François; Scarfe, Andrew G; Middleton, Mark R; Anthoney, Alan; Halloran, Christopher M; Mayerle, Julia; Oláh, Attila; Jackson, Richard; Rawcliffe, Charlotte L; Scarpa, Aldo; Bassi, Claudio; Büchler, Markus W |
| 5 | 8-Nov-2013 | The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study. | Carter, Hannah E; Zannino, Diana; John Simes, R; Schofield, Deborah J; Howard, Kirsten; Zalcberg, John R; Price, Timothy J; Tebbutt, Niall C |
| 6 | 16-Sep-2013 | Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study. | Ohtsu, Atsushi; Ajani, Jaffer A; Bai, Yu-Xian; Bang, Yung-Jue; Chung, Hyun-Cheol; Pan, Hong-Ming; Sahmoud, Tarek; Shen, Lin; Yeh, Kun-Huei; Chin, Keisho; Muro, Kei; Kim, Yeul Hong; Ferry, David; Tebbutt, Niall C ; Al-Batran, Salah-Eddin; Smith, Heind; Costantini, Chiara; Rizvi, Syed; Lebwohl, David; Van Cutsem, Eric |
Loading...
2
0
20
0
false